Full Citation

Title: FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis

Citation Type: Journal Article

Publication Year: 2019

ISBN:

ISSN: 1468-0009

DOI:

NSFID:

PMCID:

PMID:

Abstract: The World Health Organization has recommended sodium reduction as a “best buy” to prevent cardiovascular disease (CVD). Despite this, Congress has temporarily blocked the US Food and Drug Administration (FDA) from implementing voluntary industry targets for sodium reduction in processed foods, the implementation of which could cost the industry around $16 billion over 10 years. We modeled the health and economic impact of meeting the two-year and ten-year FDA targets, from the perspective of people working in the food system itself, over 20 years, from 2017 to 2036. Benefits of implementing the FDA voluntary sodium targets extend to food companies and food system workers, and the value of CVD-related health gains and cost savings are together greater than the government and industry costs of reformulation.

Url: https://onlinelibrary.wiley.com/doi/pdf/10.1111/1468-0009.12402

User Submitted?: No

Authors: Collins, Brendan; Kypridemos, Chris; Pearson-Stuttard, Jonathan; Huang, Yue; Bandosz, Piotr; Wilde, Parke; Kersh, Rogan; Capewell, Simon; O'Flaherty, Martin

Periodical (Full): The Milbank Quarterly

Issue: 3

Volume: 97

Pages: 858-880

Data Collections: IPUMS USA

Topics: Health

Countries: